Description: BioGaia Gastrus Probiotic Chewable Tablets Tangerine/Mint Flavor, Chew.TabsProbiotics for children and adults for stomach health, in chewable tablets with tangerine/mint flavor.Gastritis Helicobacter | Stomach disordersBioGaiaGastrus® probiotic chewable tablets are a simple, natural, safe and easy way to restore and maintain healthy microbial balance in the gastrointestinal tract, reduce gastrointestinal inflammation as well as treat functional gastrointestinal disorders caused by eradication therapy Helicobacter pylori.Specially designed and clinically proven to prevent and treat stomach-related problemsUnique combination of 2 probiotic strains with complementary propertiesClinically studied combinationUnique parallel natural prebiotic action due to their natural structureClinically proven unique dual action, anti-pathogenic and anti-inflammatoryClinically studied combinationContains the world's most studied probiotic strain in infants and children, one of the three most studied in adultsStrains isolated in humans (of human origin)Clinically studied by clinical benefit and age groupSafe for children and adults, during pregnancy and breastfeeding and by diabeticsIt is protected by patentsDoes not contain sugar, lactose, gluten, milk proteinThe world's first probiotic, specially designed for the treatment of Helicobacter pylori eradication and the treatment of stomach disorders.For children over 3 years old and adults.Contains the unique probiotic strains Limosilactobacillus reuteri ATCC PTA 6475 (formerly known as Lactobacillus reuteri Protectis®) + Limosilactobacillus reuteri ATCC PTA 6475Strains isolated in humans (of human origin)Unique combination of 2 probiotic strains with common and complementary propertiesDouble unique action, anti-pathogenic and anti-inflammatoryClinically studied combinationClinically studied by clinical benefit and age groupSafe for children and adults, during pregnancy and breastfeeding and by diabeticsThis biofilm:a) Protects the probiotic strain that surrounds it, from other microorganisms, antibiotics, toxic compounds, osmotic agentsb) While for the organism. It inhibits the adhesion of pathogens to the intestinal epithelium. It supports the symbiotic microflora by acting as a prebiotic (food). Regulates immunity by activating T regulatory cells and increasing anti-inflammatory cytokinesIn other words, we have a probiotic that also has prebiotic properties. By nature!USEGastritis | Prevention & Treatment:1 tablet dailyHelicobacter pylori eradication & gastrointestinal upset from the antibiotic (diarrhea, abdominal pain, flatulence) | Prevention & Treatment:1 tablet daily during eradication therapy1 tablet daily for 2-3 weeks after the eradication treatmentStomach disorders (indigestion, bloating, stomach pain, reductions, etc.) | Treatment:1 ? 2 tablets daily or based on individual needsScientifically proven to reduce inflammation levels, such as in gastritis (reduction of gastrin-17 and TNF-?).Scientifically proven to reduce symptoms and side effects from taking strong antibiotic therapy and taking antibiotics for a long time.Scientifically proven to reduce dysbiosis caused by taking antibiotics and proton pump inhibitors (PPIs/prazoles).Scientifically proven to increase the rate of gastric emptyingScientifically proven to reduce the side effects of Helicobacter pylori eradication therapy, increase its eradication rate and improve patient compliance to treatment.Clinically proven to improve digestive health and function.Absolutely safe.Simple dosage regimen (1 tablet / day).BioGaia Gastrus ® chewable tablets contain the clinically studied combination of two probiotic strains, L . reuteri Protectis ® and L . reuteri ATCC PTA 6475. L .reuteri Protectis ® ( L . reuteri DSM 17938) the proprietary probiotic bacterium of BioGaia Sweden, originally isolated in breast milk, is the most studied probiotic worldwide in infants and children and one of the three most studied in adults. Its safety and effectiveness have been proven in 217 clinical studies and 180 scientific journal publications (last updated: January 2020).L.reuteri Protectis ® and L .? reuteri ATCC PTA 6475 fully meet the requirements of the P.O.Y. for probiotics. In an in vitro study comparing the viability of 35 different probiotic strains in a simulated human gastrointestinal tract over five days, L. reuteri Protectis ® was shown to be one of only three strains that survived. This fact was also confirmed in vivo, when its intake by healthy people led to significant colonization of the stomach, duodenum and ileum.L. reuteri Protectis ® colonizes the entire gastrointestinal tract, prevents the growth of harmful microorganisms, activates the immune system and improves gastrointestinal function.It is also the only probiotic that produces the antimicrobial substance reuterin against pathogenic microorganisms, so it has a unique anti-pathogenic effect which is ideally complemented by L . reuteri ATCC PTA 6475 which combines the outstanding property of surviving in the hostile environment of the stomach for more than 3 hours and providing its clinically proven anti-inflammatory effect.
Price: 69 USD
Location: ATHENS
End Time: 2024-12-27T19:02:05.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 14 Days
Refund will be given as: Money Back
Brand: biogaia
Formulation: Chewable
